百丰医药 (872260.OC)

+ 收藏

现金流量表(百丰医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 124,895,093.57342,784,808.65167,837,754.66322,882,325.53138,551,856.79
 收到的税费返还(元) -72,850.5382,510.59--
 收到其他与经营活动有关的现金(元) 40,929,132.9929,751,078.3622,824,270.6668,591,238.1633,328,037.23
 经营活动现金流入小计(元) 165,824,226.56372,608,737.54190,744,535.91391,473,563.69171,879,894.02
 购买商品、接受劳务支付的现金(元) 97,134,069.62277,012,871.43132,550,881.16292,738,980.64131,844,838.59
 支付给职工以及为职工支付的现金(元) 1,618,828.764,843,729.481,856,524.873,989,453.841,966,312.14
 支付的各项税费(元) 2,543,135.5512,140,120.406,629,572.598,493,171.254,136,050.19
 支付其他与经营活动有关的现金(元) 43,200,725.0984,604,297.7644,755,621.5478,835,674.2539,139,293.88
 经营活动现金流出小计(元) 144,496,759.02378,601,019.07185,792,600.16384,057,279.98177,086,494.80
 经营活动产生的现金流量净额(元) 21,327,467.54-5,992,281.534,951,935.757,416,283.71-5,206,600.78
二、投资活动产生的现金流量
 取得投资收益收到的现金(元) -5,674.0841,270.05136,090.9890,909.79
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -560.00327.43194.6846,716.98
 处置子公司及其他营业单位收到的现金净额(元) --510,000.00495,768.23-
 收到其他与投资活动有关的现金(元) -10,013,048.399,980,749.2410,523,393.098,313,732.51
 投资活动现金流入小计(元) -10,019,282.4710,532,346.7211,155,446.988,451,359.28
 购建固定资产、无形资产和其他长期资产支付的现金(元) -527,859.96284,691.811,410,884.41350,102.80
 支付其他与投资活动有关的现金(元) 3,000,000.001,000,000.00-5,178,000.00-
 投资活动现金流出小计(元) 3,000,000.001,527,859.96284,691.816,588,884.41350,102.80
 投资活动产生的现金流量净额(元) -3,000,000.008,491,422.5110,247,654.914,566,562.578,101,256.48
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---4,500,000.004,500,000.00
 取得借款收到的现金(元) ---4,656,451.802,521,930.00
 筹资活动现金流入小计(元) ---9,156,451.807,021,930.00
 分配股利、利润或偿付利息支付的现金(元) 6,862,286.165,718,000.005,718,000.005,720,584.865,718,000.00
 支付其他与筹资活动有关的现金(元) --2,329,234.40--
 筹资活动现金流出小计(元) 6,862,286.165,718,000.008,047,234.405,720,584.865,718,000.00
 筹资活动产生的现金流量净额(元) -6,862,286.16-5,718,000.00-8,047,234.403,435,866.941,303,930.00
五、现金及现金等价物净增加额(元) 11,465,181.38-3,218,859.027,152,356.2615,418,713.224,198,585.70
 加:期初现金及现金等价物余额(元) 14,575,178.8317,794,037.8517,794,037.852,375,324.632,375,324.63
 期末现金及现金等价物余额(元) 26,040,360.2114,575,178.8324,946,394.1117,794,037.856,573,910.33
补充资料:
 净利润(元) 1,075,912.498,696,662.246,733,771.4815,566,752.553,176,582.92
 固定资产和投资性房地产折旧(元) 660,685.011,282,261.32628,617.541,211,813.73608,016.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 660,685.011,282,261.32628,617.541,211,813.73608,016.96
 无形资产摊销(元) 8,721.4819,355.499,764.4621,796.2911,465.34
 长期待摊费用摊销(元) 58,992.02358,793.97302,323.55652,493.53283,847.19
 处置固定资产、无形资产和其他长期资产的损失(元) -658.4215,785.2910,510.20-28,452.8615,419.73
 财务费用(元) -122,898.12122,810.62511,665.36254,436.11
 投资损失(元) --45,124.38-45,124.38-824,085.99-90,909.79
 递延所得税(元) -142,205.9834,192.10-18,659.14-160,090.00-120,612.28
  其中:递延所得税资产减少(元) -142,205.9834,192.10-18,659.14-160,090.00-120,612.28
 存货的减少(元) 3,480,463.841,317,014.217,666,760.30-972,820.86-2,135,767.75
 经营性应收项目的减少(元) 20,335,439.0027,652,358.893,285,977.70-21,209,444.70-13,638,582.37
 经营性应付项目的增加(元) -16,720,499.82-47,068,870.89-13,811,177.4111,737,589.155,806,590.25
 现金的期末余额(元) 26,040,360.2114,575,178.8324,946,394.1117,794,037.856,573,910.33
 减:现金的期初余额(元) 14,575,178.8317,794,037.8517,794,037.852,375,324.632,375,324.63
 现金及现金等价物的净增加额(元) 11,465,181.38-3,218,859.027,152,356.2615,418,713.224,198,585.70
公告日期 2024-08-282024-04-292023-08-302023-04-262022-08-19
审计意见(境内) 保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院